Latest News about SAGE
Recent news which mentions SAGE
This Palo Alto Networks Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
November 21, 2024
From Benzinga
After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
November 20, 2024
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Sage Therapeutics
November 20, 2024
Tickers
SAGE
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 30, 2024
From Benzinga
From Benzinga
Netflix To $650? Here Are 10 Top Analyst Forecasts For Wednesday
October 09, 2024
From Benzinga
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
October 08, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 08, 2024
From Benzinga
The Analyst Verdict: Sage Therapeutics In The Eyes Of 13 Experts
October 04, 2024
Tickers
SAGE
From Benzinga
Rivian Automotive Cuts Production Outlook, Joins EVgo And Other Big Stocks Moving Lower In Friday's Pre-Market Session
October 04, 2024
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 04, 2024
From Benzinga
Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
September 26, 2024
From Benzinga
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
From Benzinga
Sage, Biogen Shelve Development Of Nervous System Disorder Drug After Data Disappoints
July 24, 2024
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.